Jenny Goudemand Selected Research

Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)

3/2009

Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jenny Goudemand Research Topics

Disease

19	Hemorrhage 07/2023 - 04/2002
11	Hemophilia A (Haemophilia) 11/2020 - 07/2003
8	von Willebrand Diseases (von Willebrand's Disease) 01/2023 - 03/2004
7	Type 1 von Willebrand Disease 01/2020 - 01/2007
7	Type 2 von Willebrand Disease 12/2019 - 06/2002
5	Type 3 von Willebrand Disease 01/2023 - 01/2020
5	Aortic Valve Stenosis (Aortic Stenosis) 07/2016 - 07/2003
2	Epistaxis (Nosebleed) 01/2020 - 04/2002
2	Hemophilia B (Haemophilia B) 05/2019 - 07/2015
2	Aortic Valve Insufficiency (Aortic Regurgitation) 07/2016 - 03/2015
2	Thrombasthenia (Glanzmann Thrombasthenia) 05/2015 - 03/2010
1	Adenocarcinoma 07/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	Angiodysplasia 01/2021
1	Hemarthrosis 01/2020
1	Menorrhagia 01/2020
1	Thrombocytopenia (Thrombopenia) 12/2019
1	Vascular System Injuries 03/2016
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2012
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 03/2009
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 10/2008
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2007
1	Pathologic Constriction (Stenosis) 07/2003

Drug/Important Bio-Agent (IBA)

28	von Willebrand FactorIBA 07/2023 - 06/2002
11	Factor VIII (Coagulation Factor VIII)IBA 01/2023 - 06/2002
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2007
4	Hemostatics (Antihemorrhagics)IBA 01/2020 - 07/2003
3	AntigensIBA 01/2020 - 03/2007
3	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 03/2013 - 03/2004
2	IsoantibodiesIBA 01/2023 - 07/2021
2	Glycoproteins (Glycoprotein)IBA 03/2016 - 06/2006
2	CollagenIBA 03/2013 - 07/2003
2	factor VII clotting antigenIBA 07/2003 - 04/2002
1	AntibodiesIBA 01/2023
1	Capsules (Microcapsules)IBA 01/2021
1	3' Untranslated Regions (3' UTR)IBA 11/2020
1	A-factor (Streptomyces)IBA 01/2020
1	emicizumabIBA 09/2019
1	Factor V (Coagulation Factor V)IBA 08/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 05/2019
1	Fibrinogen (Factor I)FDA Link 05/2019
1	Neutralizing AntibodiesIBA 01/2018
1	Adenosine Diphosphate (ADP)IBA 07/2016
1	Factor XIII (Coagulation Factor XIII)IBA 01/2016
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 07/2015
1	IntegrinsIBA 05/2015
1	Proteins (Proteins, Gene)FDA Link 11/2014
1	Messenger RNA (mRNA)IBA 03/2010
1	Platelet Glycoprotein GPIIb-IIIa ComplexIBA 03/2010
1	Fibrinogen ReceptorsIBA 03/2010
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 03/2009
1	EnzymesIBA 06/2006
1	ImmunosorbentsIBA 06/2006
1	Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA 06/2006
1	Rituximab (Mabthera)FDA Link 01/2006
1	CoagulantsIBA 03/2004
1	recombinant FVIIa (rFVIIa)FDA Link 07/2003
1	Factor VIIa (Activated Factor VII)IBA 07/2003
1	Factor VII (Proconvertin)IBA 04/2002

Therapy/Procedure

5	Therapeutics 01/2023 - 04/2002
2	Transcatheter Aortic Valve Replacement 07/2016 - 03/2015
2	Heart-Assist Devices 01/2016 - 03/2015
1	Colectomy 07/2023
1	Argon Plasma Coagulation 01/2021
1	Ligation 01/2020
1	Tooth Extraction (Tooth Extractions) 01/2020
1	Prostheses and Implants (Prosthesis) 07/2003
1	Minor Surgical Procedures (Minor Surgery) 04/2002